Suppr超能文献

结直肠癌切除术后患者的第二原发癌和复发:日本临床肿瘤学组试验的综合分析:JCOG1702A。

Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A.

机构信息

Japan Clinical Oncology Group (JCOG) Data Center/Operations Office, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Division of Clinical Oncology, Kochi Health Sciences Center, 2125-1 Ike, Kochi, Kochi, Japan.

出版信息

Jpn J Clin Oncol. 2021 Feb 8;51(2):185-191. doi: 10.1093/jjco/hyaa184.

Abstract

BACKGROUND

Improvements in early detection and treatment have resulted in an increasing number of long-term survivors of colorectal cancer (CRC). For the survivors, second primary cancer and recurrence are important issues; however, evidence for an appropriate surveillance strategy remains limited.This study aimed to investigate the frequency and timing of second primary cancer in patients after surgery for exploring an appropriate surveillance strategy by using an integrated analysis of three large-scale randomized controlled trials in Japan.

METHODS

The eligibility criteria of three trials included histologically confirmed CRC and having received surgery. The timing, site and frequency of second primary cancers and recurrence were investigated. Risk factors associated with second primary cancers were also examined. The standardized incidence ratio (SIR) of second primary cancers compared with the national database of the Japan Cancer Registry was estimated.

RESULTS

A total of 2824 patients were included in this study. The cumulative incidence of second primary cancer increased over time. The SIR of any second primary cancer was 1.07 (95% CI: 0.94-1.21). The SIR for second primary cancers of colon was 1.09 (95% CI: 0.79-1.47). The cumulative incidence of recurrence almost reached plateau at 3 years.

CONCLUSIONS

A common surveillance strategy for the general population can be applied even for curatively resected CRC patients, as the risk of second primary cancers was almost the same as that of the general population.

摘要

背景

由于早期检测和治疗的改进,结直肠癌(CRC)的长期幸存者人数不断增加。对于幸存者来说,第二原发癌和复发是重要的问题;然而,适当的监测策略的证据仍然有限。本研究旨在通过对日本三项大规模随机对照试验的综合分析,探讨手术后患者第二原发癌的发生频率和时间,以探索一种合适的监测策略。

方法

三项试验的纳入标准包括组织学证实的 CRC 和接受过手术。调查了第二原发癌和复发的时间、部位和频率,并检查了与第二原发癌相关的危险因素。用日本癌症登记处全国数据库估计了第二原发癌的标准化发病比(SIR)。

结果

共有 2824 名患者纳入本研究。第二原发癌的累积发生率随时间推移而增加。任何第二原发癌的 SIR 为 1.07(95%CI:0.94-1.21)。结肠第二原发癌的 SIR 为 1.09(95%CI:0.79-1.47)。复发的累积发生率在 3 年内几乎达到平台期。

结论

即使是接受根治性手术的 CRC 患者,也可以应用普通人群的共同监测策略,因为第二原发癌的风险几乎与普通人群相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验